Systemic drug therapy for restenosis: "déjà vu all over again".
- 29 October 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (18) , 2296-8
- https://doi.org/10.1161/01.cir.0000038412.38399.d5
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Oral Everolimus Inhibits In-Stent Neointimal GrowthCirculation, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Inhibition of Vascular Smooth Muscle Cell Proliferation, Migration, and Survival by the Tumor Suppressor Protein PTENArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- RestenosisPublished by Taylor & Francis ,2001
- Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?Cardiovascular Research, 1998
- Arterial Remodeling: A Critical Factor in RestenosisPublished by Springer Nature ,1997